Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4556 Gene Editing

Trading 10-02 10:41:09 EDT

442.92

+1.16

+0.26%

High459.99	Low441.38	Vol2.42M
Open443.56	D1 Closing441.75	Amplitude4.21%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O44.74M	T/O Rate--	Tradable Shares0.00
P/B2.708227	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":442.91525,"timestamp":1790952069075,"preClose":441.75034,"halted":0,"volume":2424303,"delay":0,"changeRate":0.002637,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":1.164917,"latestTime":"10-02 10:41:09 EDT","open":443.5647,"high":459.98694,"low":441.3751,"amount":44743911.524732,"amplitude":0.042132,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.708227,"peRate":-9.763756,"turnoverRate":0.005543,"increases":3,"decrements":1,"flats":0,"marketCap":9988709920,"floatMarketCap":9379756704},"requestUrl":"/m/hq/s/BK4556/","defaultTab":"news","newsList":[{"id":"2672962837","title":"CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2672962837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672962837?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:19","pubTimestamp":1790903982,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics has delivered a mixed share price story over the past few years, and that uneven run puts fresh attention on what investors are really paying for on its balance sheet. With the stock now around US$55, the key issue is how that market value lines up against the company’s book value today.\n\nOver the past 5 years the share price has fallen 46.2%, which puts long term holders in focus and raises the question of whether the current valuation is still anchored to the underlying...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-command-a-premium-on-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-command-a-premium-on-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","SYNB","EQR","BK4215","BK4585","LU1861559042.SGD","CRSP","REZ","LU1861558580.USD","BK4556","BK4611","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672590667","title":"Intellia Therapeutics (NTLA), What Is Drawing Fresh Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672590667","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672590667?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:17","pubTimestamp":1790849853,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) has stayed in focus after recent price moves, with the stock closing at US$12.06. Investors are weighing that level against the company’s clinical-stage CRISPR pipeline and collaboration footprint.\nFor context, the recent move around US$12.06 comes after a year where the share price return is up 30.94% year to date, but the 1 year total shareholder return has declined 41%, so momentum has picked up in the short term while longer term holders still face heavy...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/intellia-therapeutics-ntla-what-is-drawing-fresh-attention-n","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/intellia-therapeutics-ntla-what-is-drawing-fresh-attention-n","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","LU1861559042.SGD","BK4535","LU1861558580.USD","BK4556","NTLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672355627","title":"Cathie Wood’s ARK Investment buys 467K shares of Intellia Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2672355627","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672355627?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:45","pubTimestamp":1790815508,"startTime":"0","endTime":"0","summary":"20:44 EDT Cathie Wood’s ARK Investment buys 467K shares of Intellia Therapeutics (NTLA) today Published first on TheFly – the ultimate source for r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-467k-shares-of-intellia-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-467k-shares-of-intellia-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4544","BK4588","BK4139","LU1861558580.USD","ARKX","ARKF","ARKQ","LU1861559042.SGD","ARKK","BK4535","ARKW","BK4585","NTLA","SARK","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670484284","title":"ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670484284?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:14","pubTimestamp":1790579642,"startTime":"0","endTime":"0","summary":"ToolGen Incorporated ( ($KR:199800) ) has shared an update. ToolGen has completed a KRW 19.46 billion paid-in capital increase via a rights offerin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","LU1861559042.SGD","CRSP","BK4588","BK4611","ARKG","BK4585","BK4556","LU1861558580.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471230","title":"Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471230?lang=en_us&edition=fundamental","pubTime":"2026-09-26 21:00","pubTimestamp":1790427654,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($SNOW)), (($PANW)), (($DELL)), (($GME)) and (($CRSP)). Here is a breakdown of their recent trades and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IGV","LU0052756011.USD","LU2290526834.HKD","SNOY","BK4613","LU2023250504.SGD","LU2322448791.USD","BK4588","BK4556","LU1548497426.USD","LU1992135472.HKD","SPAM","BUG","LU2272731782.SGD","HAKY","BK4503","WCBR","LU2250418816.HKD","LU0348723411.USD","LU2265009873.SGD","LU1169590202.USD","LU2272731865.HKD","LU2360106780.USD","LU2360107168.USD","PANG","LU1861559042.SGD","BK4547","DELL","LU2065170008.USD","LU1923622291.USD","LU0719512351.SGD","LU1861220033.SGD","DAT","LU1823568750.SGD","BK4560","BK4170","XDAT","BK4532","IE00BKVL7J92.USD","BK4559","LU1720051017.SGD","BK4139","LU0310800965.SGD","LU2473716301.USD","LU0345770993.USD","LU2095319765.USD","LU1951200564.SGD","LU2286300806.USD","LU1861558580.USD","IE00B19Z8W00.USD","LU1169589451.USD","LU1974910355.USD","BK4550","LU0234570918.USD","LU0128525689.USD","IHAK","BK4535","LU2125909916.SGD","WISE","PSWD","IGME","BK4581","LU0823434583.USD","LU1235294995.USD","LU0109392836.USD","LU1712237335.SGD","SNOU","IE00BZ1G4Q59.USD","BK4505","LU0976567544.SGD","LU2023250843.SGD","LU0081259029.USD","DLLL","BK4577","LU0211326755.USD","FXL","LU0345770308.USD","LU0823421333.USD","PANW","LU1861215975.USD","LU0889565833.HKD","BK4611","LU2210149790.SGD","GMEY","LU0056508442.USD","BK4551","BK4585","LU0496365809.HKD","LU1623119135.USD","BK4097","LU1267930227.SGD","LU1046421795.USD","LU2322448957.HKD","LU2210150020.SGD","LU1989764748.USD","GME","BK4515","AIFD","LU0266013472.USD","CLOD","LU1720051108.HKD","LU1989764664.SGD","LU2065169927.USD","LU1923623000.USD","PALD","BK4554","SNOW","CIBR","LU0823434740.USD","GMEC","LU1951198990.SGD","BK4598","IE00BMPRXR70.SGD","LU1803068979.SGD","LU1992135399.USD","BK4076","LU0097036916.USD","BK4543","LU1804176565.USD","LU2065171402.SGD","LU2065171311.SGD","GMEU","WCLD","CLOU","IE00B19Z8X17.USD","WLDR","LU2106854487.HKD","CRSP","LU2355687059.USD","IE00BMPRXN33.USD","LU0267386448.USD","BK4116","LU1917777945.USD","LU0823421416.USD","LU0211326839.USD","LU1852331112.SGD","IE00B19Z9505.USD","SG9999001424.SGD","LU2357305700.SGD","LU0082616367.USD","BK4607","LU2272731600.USD","LU2125909759.SGD","BK4548","ARKG","PALU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413710","title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413710","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413710?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:35","pubTimestamp":1790285746,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics General Counsel James R. Kasinger disposes of common shares worth $626,459.6James R. Kasinger, general counsel and secretary, sold 10,400 common shares on Sept. 22 at USD 60.2365.T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3lyBzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","ARKG","BK4139","BK4611","BK4588","BK4585","BK4556","CRSP","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435367","title":"Editas slips amid pressure on gene-editing sector after Anthropic update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435367?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:55","pubTimestamp":1790189712,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) is trading lower alongside other gene editing peers after Anthropic shared early findings on a CRISPR like enzyme system. An...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","LU1861558580.USD","EDIT","GNMX","BK4585","HELX","IDNA","WDNA","BK4139","CRSP","BK4556","SYNB","ARKG","LU1861559042.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433986","title":"Claude discovers novel enzyme system with CRISPR-like repeats","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669433986?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:15","pubTimestamp":1790187313,"startTime":"0","endTime":"0","summary":"Anthropic is introducing a new life sciences research group and laboratory, with a focus on fundamental biology research using Claude – exploring d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4556","SYNB","LU1861558580.USD","BK4611","CRSP","BK4585","LU1861559042.SGD","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669048573","title":"Editas Medicine Raised to Buy from Neutral by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2669048573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669048573?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:39","pubTimestamp":1790167140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EDIT/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","EDIT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669007891","title":"Guggenheim Upgrades Editas Medicine to Buy From Neutral, Price Target is $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2669007891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669007891?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:09","pubTimestamp":1790161752,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) has an average rating of overweight and mean price target of $4.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4556","BK4139","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669911491","title":"Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics  today","url":"https://stock-news.laohu8.com/highlight/detail?id=2669911491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669911491?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:30","pubTimestamp":1790037011,"startTime":"0","endTime":"0","summary":"20:28 EDT Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4556","BK4585","BK4535","BK4611","ARKK","ARKQ","SARK","LENZ","LU1861558580.USD","BK4588","ARKF","LU1861559042.SGD","BK4544","ARKX","BEAM","BK4139","BK4505","ARKG","ARKW","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843196","title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:41","pubTimestamp":1790030476,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics director Ali Behbahani disposes of common shares worth $780,649.24CRISPR Therapeutics director Ali Behbahani exercised stock options for 30,000 common shares at USD 14 on Sept. 17,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL112S6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4585","BK4139","BK4588","BK4611","CRSP","ARKG","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4556","nameEN":"BK4556"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Gene Editing,BK4556,Gene Editing股票,Gene Editing股票老虎,Gene Editing股票老虎国际,Gene Editing行情,Gene Editing股票行情,Gene Editing股价,Gene Editing股市,Gene Editing股票价格,Gene Editing股票交易,Gene Editing股票购买,Gene Editing股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gene Editing(BK4556),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Gene Editing(BK4556) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}